Lipoteichoic acid acts as an antagonist and an agonist of lipopolysaccharide on human gingival fibroblasts and monocytes in a CD14- dependent manner

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1623-1632

  Sugawara, Shunji ^a   Arakaki, Rieko ^b   Rikiishi, Hidemi ^a   Takada, Haruhiko ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; INTERLEUKIN 8; LIPID A; LIPOTEICHOIC ACID; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE;

AGONIST; ARTICLE; BACILLUS SUBTILIS; CONTROLLED STUDY; FIBROBLAST; GINGIVA; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; STREPTOCOCCUS MUTANS; STREPTOCOCCUS SANGUINIS;

EID: 0033041977     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/.67.4.1623-1632.1999     Document Type: Article

References (45)

1. Abo, T., S. Sugawara, A. Amenomori, H. Itoh, H. Rikiishi, I. Moro, and K. Kumagai. 1986. Selective phagocytosis of gram-positive bacteria and interleukin 1-like factor production by a subpopulation of large granular lymphocytes. J. Immunol. 136:3189-3197.
2. Aida, Y., K. Kusumoto, K. Nakatomi, H. Takada, M. J. Pabst, and K. Maeda. 1995. An analogue of lipid A and LPS from Rhodobacter sphaeroides inhibits neutrophil responses to LPS by blocking receptor recognition of LPS and by depleting LPS-binding protein in plasma. J. Leukocyte Biol. 58:675-682.
3. Ashida, M., and H. I. Yamazaki. 1990. Biochemistry of the phenoloxidase system in insects: with special reference to its activation, p. 239-265. In E. Ohnishi and H. Ishizaki (ed.), Molting and metamorphosis. Japan Scientific Societies Press, Tokyo, Japan.
4. Bhakdi, S., T. Klonisch, P. Nuber, and W. Fischer. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59:4614-4620.
5. Bucher, M., K. P. Ittner, M. Zimmermann, K. Wolf, J. Hobbhahn, and A. Kurtz. 1997. Nitric oxide synthase isoform III gene expression in rat liver is up-regulated by lipopolysaccharide and lipoteichoic acid. FEBS Lett. 412: 511-514.
6. Cleveland, M. G., J. D. Gorham, T. L. Murphy, E. Tuomanen, and K. M. Murphy. 1996. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1906-1912.
7. Espevik, T., M. Otterlei, G. Skjåk-Bræk, L. Ryan, S. D. Wright, and A. Sundan. 1993. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 23:255-261.
8. Fischer, W. 1990. Bacterial phosphoglycolipids and lipoteichoic acids, p. 123-234. In M. Kates (ed.), Handbook of lipid research, vol. 6. Glycolipids, phosphoglycolipids, and sulfoglycolipids. Plenum Press, New York, N.Y.
9. Fischer, W., H. U. Koch, and R. Haas. 1983. Improved preparation of lipoteichoic acids. Eur. J. Biochem. 133:523-530.
10. Galanos, C., O. Lüderitz, and O. Westphal. 1979. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 Orig. Reihe A 243:226-244.
11. Golenbock, D. T., R. Y. Hampton, N. Qureshi, K. Takayama, and C. R. H. Raetz. 1991. Lipid A-like molecules that antagonize the effect of endotoxins on human monocytes. J. Biol. Chem. 266:19490-19498.
12. Golenbock, D. T., W. A. Lynn, R. Y. Hampton, F. H. Millham, and Y. Liu. 1993. Characterization of LPS signaling pathways with the LPS inhibitors lipid IVa (1A, LA-14-PP) and Rhodobacter sphaeroides lipid A, p. 349-359. In J. Levin, C. R. Alving, R. S. Munford, and P. L. Stutz (ed.), Bacterial endotoxin: recognition and effector mechanisms. Elsevier Science Publishers B. V., Amsterdam, The Netherlands.
13. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269-277.
14. Hashimoto, M., J. Yasuoka, Y. Suda, H. Takada, T. Yoshida, S. Kotani, and S. Kusumoto. 1997. Structural feature of the major but not cytokine-inducing molecular species of lipoteichoic acid. J. Biochem. 121:779-786.
15. Jarvis, B. W., H. Lichenstein, and N. Qureshi. 1997. Diphosphoryl lipid A from Rhodobacter sphaeroides inhibits complexes that form in vitro between lipopolysaccharide (LPS)-binding protein, soluble CD14, and spectrally pure LPS. Infect. Immun. 65:3011-3016.
16. Keller, R., W. Fischer, R. Keist, and S. Bassetti. 1992. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60:3664-3672.
17. Kochanowski, B., W. Fischer, N. Iida-Tanaka, and I. Ishizuka. 1993. Isomalto-oligosaccharide-containing lipoteichoic acid of Streptococcus sanguis. Basic structure. Eur. J. Biochem. 214:747-755.
18. Kusunoki, T., E. Hailman, T. S.-C. Juan, H. S. Lichenstein, and S. D. Wright. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182:1673-1682.
19. Kusunoki, T., and S. D. Wright. 1996. Chemical characteristics of Staphylococcus aureus molecules that have CD14-dependent cell-stimulating activity. J. Immunol. 157:5112-5117.
20. Loppnow, H., H. Brade, I. Durrbaum, C. A. Dinarello, S. Kusumoto, E. T. Rietschel, and H.-D. Flad. 1989. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J. Immunol. 142:3229-3238.
21. Morrissey, J. H. 1981. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117: 307-310.
22. Nisengard, R. J., M. G. Newman, and J. J. Zambon. 1994. Periodontal disease, p. 360-384. In R. J. Nisengard and M. G. Newman (ed.), Oral microbiology and immunology, 2nd ed. The W. B. Saunders Co., Philadelphia, Pa.
23. Obayashi, T., H. Tamura, S. Tanaka, M. Ohki, S. Takahashi, M. Arai, M. Masuda, and T. Kawai. 1985. A new chromogenic endotoxin-specific assay using recombined Limulus coagulation enzymes and its clinical applications. Clin. Chim. Acta 149:55-65.
24. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
25. Sellati, T. J., D. A. Bouis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. C. Gangloff, S. M. Goyert, M. V. Norgard, and J. D. Radolf. 1998. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J. Immunol. 160:5455-5464.
26. Soell, M., E. Lett, F. Holveck, M. Schöller, D. Wachsmann, and J.-P. Klein. 1995. Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-α release. J. Immunol. 154:851-860.
27. Sugawara, S., A. Sugiyama, E. Nemoto, H. Rikiishi, and H. Takada. 1998. Heterogeneous expression and release of CD14 by human gingival fibroblasts: characterization and CD14-mediated interleukin-8 secretion in response to lipopolysaccharide. Infect. Immun. 66:3043-3049.
28. Sugiyama, A., R. Arakaki, T. Ohnishi, N. Arakaki, Y. Daikuhara, and H. Takada. 1996. Lipoteichoic acid and interleukin 1 stimulate synergistically production of hepatocyte growth factor (scatter factor) in human gingival fibroblasts in culture. Infect. Immun. 64:1426-1431.
29. Takada, H., Y. Kawabata, R. Arakaki, S. Kusumoto, K. Fukase, Y. Suda, T. Yoshimura, S. Kokeguchi, K. Kato, T. Komuro, N. Tanaka, M. Saito, T. Yoshida, M. Sato, and S. Kotani. 1995. Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect. Immun. 63:57-65.
30. Takada, H., and S. Kotani. 1989. Structural requirements of lipid A for endotoxicity and other biological activities. Crit. Rev. Microbiol. 16:477-523.
31. Takada, H., and S. Kotani. 1994. Immunomodulating activities of streptococcal lipoteichoic acids, p. 309-328. In N. Masihi (ed.), Immunotherapy of infections. Marcel Dekker, Inc., New York, N.Y.
32. Takada, H., J. Mihara, I. Morisaki, and S. Hamada. 1991. Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated with Bacteroides lipopolysaccharides. Infect. Immun. 59:295-301.
33. Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457.
34. Usami, H., A. Yamamoto, Y. Sugawara, S. Hamada, T. Yamamoto, K. Kato, S. Kokeguchi, H. Takada, and S. Kotani. 1987. A nontoxic tumor necrosis factor induced by streptococcal lipoteichoic acids. Br. J. Cancer 56:797-799.
35. Usami, H., A. Yamamoto, W. Yamashita, Y. Sugawara, S. Hamada, T. Yamamoto, K. Kato, S. Kokeguchi, H. Ohokuni, and S. Kotani. 1988. Antitumor effects of streptococcal lipoteichoic acids on Meth A fibrosarcoma. Br. J. Cancer 57:70-73.
36. Weidemann, B., H. Brade, E. T. Rietschel, R. Dziarski, V. Bazil, S. Kusumoto, H. Flad, and A. J. Ulmer. 1994. Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect. Immun. 62:4709-4715.
37. Wicken, A. J., and K. W. Knox. 1980. Bacterial cell surface amphiphiles. Biochim. Biophys. Acta 604:1-26.
38. Wooten, R. M., T. B. Morrison, J. H. Weis, S. D. Wright, R. Thieringer, and J. J. Weis. 1998. The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J. Immunol. 160:5485-5492.
39. Wright, S. D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6-9.
40. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
41. Yamamoto, A., H. Usami, M. Nagamuta, Y. Sugawara, S. Hamada, T. Yamamoto, K. Kato, S. Kokeguchi, and S. Kotani. 1985. The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis. Br. J. Cancer 51:739-742.
42. Yu, B., and S. D. Wright. 1996. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol Chem. 271:4100-4105.
43. Yu, S., N. Nakashima, B. H. Xu, T. Matsuda, A. Izumihara, N. Sunahara, T. Nakamura, M. Tsukano, and T. Matsuyama. 1998. Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol. Int. 17:237-243.
44. Zhang, Y., M. Doerfler, T. C. Lee, B. Guillemin, and W. N. Rom. 1993. Mechanisms of stimulation of interleukin-1β and tumor necrosis factor-α by Mycobacterium tuberculosis components. J. Clin. Investig. 91:2076-2083.
45. Ziegler-Heitbrock, H. W. L., and R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121-125.